This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Don't Buy JCP's False Hope, Misleading Optimism

NEW YORK ( TheStreet) -- It's stories such as J. C. Penney Touts Silver Lining in Poor Results that reaffirm what a great idea it was for TheStreet to buy TheDeal last year.

Stories out of The Deal Newsroom tend to not mince words. Great information that cuts through the crap and tells it like it is.

Consider The Deal's take on J. C. Penney's (JCP - Get Report) quarterly results and subsequent misguided stock price pop:

Shareholders' newfound optimism was based on company guidance for a brighter fourth quarter, as it said comparable store sales and gross margin were "expected to improve sequentially and year-over-year."

Yet third quarter numbers ... show that J.C. Penney is still on its way down, with comparable store sales declining 4.8%, revenues falling about 5.1% to $2.78 billion from $2.93 billion for the same period a year earlier, and a net loss of nearly $490 million.

The silver lining, according to J.C. Penney, is that comparable store sales increased 0.9% in Oct., a reversal of monthly comparable store sales declines since late 2011.

But trying to boost revenue through inventory clearance and promotional events to attain that all-important comparable store sales increases, also help drive down gross margins and increase losses. The company's gross margin dropped to 29.5% of sales in the third quarter, compared to 32.5% for the same period a year earlier.

You're not going to find a better analysis. Somehow, unless they're merely misleading investors with their "optimism," this is all lost on JCP management. They're in dire straits no matter what they say. Like brothers in arms, JCP and almost-as-inept peer Best Buy (BBY - Get Report) ought to prepare current and prospective shareholders for a walk of shame, not the walk of life.

The only thing that gives BBY an edge in a battle of perpetual losers is that it has better product to sell than JCP. That's it. Other than this, there's no discernible difference between the two lost companies.

I'll never understand why Wall Street chases stocks like this. Unless you're a nimble day trader who has got the action, got the motion and doesn't know the names of the pieces of paper he buys, sells, flips and shorts, you have no business being in JCP. None. Management's ability to wax with even the slightest optimism after such a God-awful quarter illustrates just how useless the SEC's regulatory apparatus is.

We saw a similar flavor of tripe served back when the artist formerly known as RIM co-CEO Jim Balsillie effectively duped people into buying what are now dead Blackberry (BBRY) shares on just as toxic rhetoric.

-- Written by Rocco Pendola in Santa Monica, Calif.
Rocco Pendola is a columnist and TheStreet's Director of Social Media. Pendola makes frequent appearances on national television networks such as CNN and CNBC as well as TheStreet TV. Whenever possible, Pendola uses hockey, Springsteen or Southern California references in his work. He lives in Santa Monica.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BBY $32.73 -3.65%
JCP $8.51 -3.62%
AAPL $124.53 -1.75%
FB $85.80 -2.51%
GOOG $521.52 -1.91%

Markets

DOW 17,596.35 -350.33 -1.95%
S&P 500 2,057.64 -43.85 -2.09%
NASDAQ 4,958.4680 -122.0370 -2.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs